Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin’s Lymphoma

Non-Hodgkin’s lymphoma (NHL) is the most common hematological malignancy in adults, with B-cell lymphomas accounting for 85% of all NHLs. The most substantial advancement in the treatment of B-cell malignancies, since the advent of combination chemotherapy, has been the addition of the monoclonal an...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Dotan, Efrat, Aggarwal, Charu, Smith, Mitchell R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MediMedia USA, Inc. 2010
Konular:
Features
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2844047/
https://ncbi.nlm.nih.gov/pubmed/20442809
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller